Recruiting

Observational Study

Sponsor:

Hospital for Special Surgery, New York

Code:

NCT01656447

Conditions

Scleroderma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.

Conditions

Scleroderma

Study ID

NCT01656447

Start date

Aug, 2006

Status verified date

Oct, 2025

Completion date

Jan, 2030

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Individuals older than 18 years of age with Scleroderma

Exclusion Criteria:

  • Individuals younger than 18 years of age
  • Individuals older than 18 years of age without Scleroderma

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients with Scleroderma

Patients who have been diagnosed at any point in their life with Scleroderma will compose the cohort.

Primary outcome measure

  • Modified Rodnan Skin Score [ Time Frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years ]

Central Contacts and Locations

Central contacts

Eliza Pelrine, BA

(212)774-2123pelrinee@hss.edu

Emily Bakaj, BA

(212)774-7620bakaje@hss.edu

Locations

Hospital for Special Surgery

Recruiting

New York, New York, United States, 10021

Contacts

Eliza Pelrine, BA

212-774-2123pelrinee@hss.edu

Principal Investigator:

Robert Spiera, MD

More Information

Sponsor

Hospital for Special Surgery, New York

Last update posted

Nov 26, 2025

Last verified

Oct, 2025

Keywords

  • Scleroderma
  • Scleroderma Registry
  • Hospital for Special Surgery Scleroderma

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hospital for Special Surgery, New York on 2025-11-26.